A growing number of prescription drugs now sold in the United States are fake or counterfeit and are posing a serious safety risk to US consumers.
This author has posted recently regarding the issue of food safety in particular as it regards the recent egg recall for Salmonella outbreak. A much larger question we need ot begin asking is if we can’t control eggs in our own country how in the world we can control something as potentially dangerous as drugs. Many of these counterfeit drugs have the wrong ingredients, not enough ingredients, or are just outright fakes and tracking and tracing them from the manufacturer to the pharmacy is incredibly difficult
In the U.S. Counterfeit drugs are being intermingled with the legitimate drugs According to the World Health Organization as much as 30 percent of prescription drugs in developing countries are counterfeit and, in developed countries, counterfeit drugs make up as much as 1 percent of the market.
As more of these products enter our market the tracking and tracing of them has to become a priority of the FDA.
There are a number of tools being considered in the area of packing alternatives inspection alternatives and RFID tagging.
As much as we pressure the FDA to do their job, and they have received additional funding for inspectors over the last several years, manufacturers also have to implement significant tracking and tracing of their products as the move along the supply chain down to the unit or container level.
We look forward to and appreciate your comments.